Rivermark Medical
Rivermark Medical develops minimally invasive solutions for Benign Prostatic Hyperplasia (BPH). Their flagship product, the FloStent System, is a nitinol stent designed to restore urinary function for BPH patients with minimal discomfort and quick recovery times. The device aims to provide immediate relief while seamlessly integrating into routine urological visits.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $30M
Date: 10-Oct-2024
Investors: American Century Investments (ACI), Venture Investors Health Fund, Time BioVentures, an unnamed strategic investor, View Ventures, Cadence Healthcare Ventures, Anduril Investors LLC
Markets: Medtech, Urology
HQ: Milwaukee, Wisconsin, United States
Founded: 2021
Website: https://www.rivermarkmedical.com
LinkedIn: https://www.linkedin.com/company/rivermark-medical-inc
Crunchbase: https://www.crunchbase.com/organization/rivermark-medical-inc
Leave a Comment
Comments
No comments yet.